Pharmacology
Threat to Modern Medicines
IPN Opinion article
The WHO's plans to push subsidised local drug production in Africa threaten to worsen the problem of substandard generics, placing the most vulnerable at risk.
Counterfeit drugs
IPN Opinion article
It's not just the criminals who are threatening health with counterfeit or substandard drugs, but also the questionable procurement practices of international aid agencies.
Medicines for the poor: not the Oxfam way
IPN Opinion article
The registration of new medicines fell sharply in the last year in the USA, while Oxfam calls for a compulsory pricing structure and backs the compulsory licenses sought by Thailand and threatened by Brazil and Indonesia. There are indeed other problems facing pharmaceutical companies but the campaign against patents is a major one: when Big Pharma gives up investing in innovation, where will new medicines come from? The price of punishing Big Pharma is to punish the poor harder.
IP fixation is bad for health
IPN Opinion article
International NGO campaigns in India have given the misleading impression that patents are the single most important barrier to good health in less-developed countries. This fallacy is drawing attention away from the real causes of disease.
Philippines: Enlarged market key to lower medicine costs
IPN Opinion article
The Manila Times covers IPN's recent symposium on IP, innovation and health in Manila.
Populism versus the poor
IPN Opinion article
Innovation by India's internationally competitive scientists suffers because of protectionist policies of the Government, says Roger Bate
